RUA Life Sciences plc (RUA.L) LSE
18.40
+0.4(+2.22%)
Currency In GBp
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 6.98M |
| Enterprise Value | 4.53M |
| P/E Ratio | -76.86 |
| PEG Ratio | 0.6 |
| Price/Sales Ratio | 2.51 |
| Price/Book Ratio | 1.56 |
| Enterprise/Revenue | 2.08 |
| Enterprise/EBITDA | -24.2 |
Fiscal Year
| Fiscal Year | September 30, 2025 |
| Most Recent Quarter | September 30, 2025 |
Profitability
| Profit Margin | -0.03 |
| Operating Margin | -0.19 |
Management Effectiveness
| Return On Assets | -0.02 |
| Return On Equity | -0.02 |
Income Statement
| Revenue | 4.46M |
| Revenue/Share | 0.07 |
| Gross Profit | 3.06M |
| EBITDA | -383,335 |
| Net Income | -145,334 |
| Diluted EPS | -0 |
Balance Sheet
| Total Cash | 3.25M |
| Total Cash/Share | 0.05 |
| Total Debt | 1.35M |
| Total Debt/Equity | 0.19 |
| Current Ratio | 4.64 |
| Book Value Per Share | 0.12 |
Price History
| 52-Week Change | 53.19 |
| 52-Week High | 26.8 |
| 52-Week Low | 10.42 |
| Moving Average 50 Days | 18.19 |
| Moving Average 200 Days | 14.02 |
Statistics
| Average Volume | 295,836 |
| Shares Outstanding | 62.06M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | September 01, 2003 |
